Use our account feature to register for a free CLI account. Your new account will allow you to bookmark and organize articles and research for easy reference later - making it simple to keep track of the research that's important to you!
Register / Sign in
Search Icon
Search Icon
Use our account feature to register for a free CLI account. Your new account will allow you to bookmark and organize articles and research for easy reference later - making it simple to keep track of the research that's important to you!
Register / Sign in
close-panel

Charlotte Lozier Institute

Phone: 202-223-8073
Fax: 571-312-0544

2776 S. Arlington Mill Dr.
#803
Arlington, VA 22206

Get Notifications

Sign up to receive email updates from Charlotte Lozier Institute.

This field is for validation purposes and should be left unchanged.

Become A Defender of Life

Your donation helps us continue to provide world-class research in defense of life.

DONATE

Charlotte Lozier Institute

Phone: 202-223-8073
Fax: 571-312-0544

2776 S. Arlington Mill Dr.
#803
Arlington, VA 22206

59 results

Sort 59 results by:

Filter Applied. Clear All

Latest Posts

June 24, 2026 The Lifesaving Impact of Recently Enacted Pro-Life Laws The Lifesaving Impact of Recently Enacted Pro-Life Laws June 10, 2026 EXCLUSIVE: Many Women Blindsided By Abortion Pill Complications, New Study Shows EXCLUSIVE: Many Women Blindsided By Abortion Pill Complications, New Study Shows June 10, 2026 New Study Finds Informed Consent Gaps for Abortion Drugs as Women Report Unexpected Pain, Bleeding New Study Finds Informed Consent Gaps for Abortion Drugs as Women Report Unexpected Pain, Bleeding
Reset All Filters

Filed: CLI Amicus Brief in Idaho’s Moyle v. United States EMTALA Case

CLI recently filed an amicus brief in the case Moyle v. United States (consolidated with Idaho v. U.S.) to be…

charlotte-lozier-institute Charlotte Lozier Institute
March 25, 2024
Please login to bookmark Close

Fact Sheet: Three Problems with the FDA’s Abortion Drugs Complications Data

The FDA’s abortion drugs complications data is woefully incomplete. From 2020-2022, the six states that report complications by type of…

Filed: CLI Amicus Brief in SCOTUS Case FDA v. Alliance for Hippocratic Medicine

On March 26, SCOTUS will hear oral arguments in the case FDA v. Alliance for Hippocratic Medicine. In the case,…

CLI logo

Filed Brief: Zurawski v. Texas and Reasonable Medical Judgment

In February 2024, CLI filed a joint amicus brief with the Alliance for Hippocratic Medicine supporting Texas in the case…

CLI Authors’ Responses to Sage Concerns and Retractions

On February 5, 2024, Sage Publications retracted three peer-reviewed articles authored by affiliates of the Charlotte Lozier Institute. Prior to…

CLI logo

Lozier Institute Amicus Brief in Support of Ecuador Law Limiting Abortion

On February 19, 2024, CLI associate scholar Mary E. Harned, J.D., submitted an amicus brief on behalf of CLI to…

Public Comment: Lozier Institute on CDC’s Notice of Proposed Modifications to Assisted Reproductive Technology Program Reporting

On January 25, 2024, CLI submitted a public comment to the CDC regarding newly proposed modifications related to data collection…

Five Facts About “Life-Limiting” Fetal Conditions

Babies prenatally diagnosed with a life-limiting condition often face discrimination. Some continue to refer to these conditions as “lethal” or…

Become A Defender of Life

Your donation helps us continue to provide
world-class research in defense of life.

BECOME A PARTNER
cta-image